Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma

Clinical trial NCT05925413 · UNKNOWN

Trial details

NCT number: NCT05925413
Sponsor: Eastern Hepatobiliary Surgery Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-04-24
Primary completion: 2024-07-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.